
Week In Review: RemeGen Raises $410 Million In Shanghai IPO For mAb/Dual Therapies
7postman/E+ via Getty Images Deals and Financings RemeGen (OTCPK:REGMF) (SHA: 688331; HK: 9995), a Yantai biotech with a deep portfolio of antibody and dual therapies, completed a $410 million IPO on the Shanghai Star Exchange […]